Potential treatment for heart attacks discovered by researchers 4 October 2019 | By Victoria Rees (Drug Target Review) Researchers have uncovered a treatment that may be used to treat heart attacks or to prevent heart failure, using the circadian clock.
NKAP gene mutation linked to rare developmental disease 3 October 2019 | By Victoria Rees (Drug Target Review) A study has revealed that a mutation in the NKAP gene causes a rare syndrome, providing researchers with the potential to develop treatments for the condition.
Three-dimensional structure of the genome replication machine discovered 3 October 2019 | By Rachael Harper (Drug Target Review) New research provides insights into how cancers can arise when DNA polymerase delta is not functioning properly.
Researchers discover new pathway to treat Ewing sarcoma 3 October 2019 | By Victoria Rees (Drug Target Review) A study has demonstrated that blocking certain receptors in mice reduced Ewing sarcoma growth and metastasis, which could be used within future treatments.
Protein responsible for muscle degeneration identified 2 October 2019 | By Victoria Rees (Drug Target Review) A study has demonstrated that a certain protein is critical in the decline of muscle regeneration, with the researchers also showing how to inhibit this process in mice.
In vitro toxicology and toxicity testing market to exhibit CAGR of 9.3 percent 2 October 2019 | By Victoria Rees (Drug Target Review) The worldwide market for in vitro toxicology and toxicity testing is predicted to be worth $12.7 billion by the end of the forecast period.
CRISPR-Cas9 variant shows high precision in gene editing 2 October 2019 | By Nikki Withers (Drug Target Review) The newly identified variant could play a role in gene therapies that require high accuracy and precision.
Weapon bacteria could be copied to create new forms of antibiotics 1 October 2019 | By Rachael Harper (Drug Target Review) New antibiotics could be designed by discovering the mechanism a weapon bacteria uses to vanquish their competitors.
New technique developed for regenerative medicine uses light 1 October 2019 | By Rachael Harper (Drug Target Review) A new study has shown that it is possible to specifically conduct the fate of tissue cells by using visible light.
Researchers fail to replicate influential neuroimaging genetics study 1 October 2019 | By Nikki Withers (Drug Target Review) These findings highlight the complexity of the relationship between genes and human brain function.
Nipah and Hendra virus attack neutralised by potent antibody 30 September 2019 | By Rachael Harper (Drug Target Review) Researchers have shown that a monoclonal antibody prevents viruses from fusing with cell membranes to gain entry.
Whole genome sequencing could be used to improve cancer treatments 30 September 2019 | By Victoria Rees (Drug Target Review) Researchers have used whole genome sequencing to analyse breast cancers and reveal which are more responsive to treatments, which could improve the development of oncologic therapies.
T cell homing beacons for lungs identified by researchers 30 September 2019 | By Rachael Harper (Drug Target Review) Molecules that are critical for T cells to travel to and populate the lungs have been identified which could strengthen vaccines against influenza.
High-throughput screening used to discover new class of antibiotics 27 September 2019 | By Victoria Rees (Drug Target Review) Researchers have used a high-throughput screening method to test over 125,000 molecules and identify a new class of antibiotics.
Neuronal link between chronic pain and depression discovered 27 September 2019 | By Victoria Rees (Drug Target Review) The mechanism in the brain connecting chronic pain and depression could lead to treatments for both, according to researchers.
